Outset Medical raises $125m funding for Tablo Hemodialysis System
US-based medical technology company Outset Medical has secured $125 million funding in a Series E financing round for the commercialization of Tablo Hemodialysis System, an enterprise solution designed to bring down the cost and complexity of dialysis. Outset Medical, based in Silicon Valley, deals with technology-driven service model innovation intended to reduce the cost and […]